Market Cap (In USD)
255 Thousand
Revenue (In USD)
140.24 Thousand
Net Income (In USD)
6.92 Million
Avg. Volume
1.15 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.0E-4-0.0134
- PE
- -
- EPS
- -
- Beta Value
- -0.629
- ISIN
- US29272H3003
- CUSIP
- 29272H300
- CIK
- 1528172
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Alan Brian Collier
- Employee Count
- -
- Website
- https://www.endonovo.com
- Ipo Date
- 2012-11-15
- Details
- Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
More Stocks
-
CHN
-
BDCM
-
FBGIFoodbase Group, Inc.
FBGI
-
VILNVillars Holding S.A.
VILN
-
RMGGYResolute Mining Limited
RMGGY
-
MULTIMulticonsult ASA
MULTI
-
SVKEF
-
603466